SCHEMBL9062199

SCHEMBL9062199

C=CCN1CCC(CCN(C)C(=O)c2ccc(S(=O)(=O)Cc3ccccc3)cc2)CC1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.59
TGM2 P21980 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501690 0.89 ACHE (0.77) ACHE
SCHEMBL9058880 0.81 ITGB3 (0.54) ACHE
SCHEMBL12043773 0.75 ACHE (1.00) ACHE
SCHEMBL7653091 0.74 ACHE (0.68) ACHE
SCHEMBL9058853 0.72 ACHE (0.47) ACHE
SCHEMBL9062193 0.72 ACHE (0.61) ACHE
SCHEMBL14601871 0.69 ACHE (0.78) ACHE
SCHEMBL7801301 0.69 ACHE (0.71) ACHE
SCHEMBL5068378 0.69 ACHE (0.76) ACHE
SCHEMBL9058701 0.69 ITGB3 (0.43) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022280-A1 N-SUBSTITUTED 1-ACYLAMINOALKYL PIPERIDINES FOR TREATMENT OF CEREBRAL DISORDERS AND DEPRESSIONS BAYER AKTIENGESELLSCHAFT (DE) 1996-07-25 WO disclosed